- Home
- BMRN vs SWK Comparison
BMRN vs SWK Comparison
Compare BMRN & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- SWK
- Stock Information
- Founded
- BMRN 1996
- SWK 1843
- Country
- BMRN United States
- SWK United States
- Employees
- BMRN N/A
- SWK N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- SWK Industrial Machinery/Components
- Sector
- BMRN Health Care
- SWK Consumer Discretionary
- Exchange
- BMRN Nasdaq
- SWK Nasdaq
- Market Cap
- BMRN 9.9B
- SWK 10.5B
- IPO Year
- BMRN 1999
- SWK N/A
- Fundamental
- Price
- BMRN $54.20
- SWK $67.91
- Analyst Decision
- BMRN Buy
- SWK Buy
- Analyst Count
- BMRN 19
- SWK 9
- Target Price
- BMRN $90.26
- SWK $92.25
- AVG Volume (30 Days)
- BMRN 2.8M
- SWK 2.0M
- Earning Date
- BMRN 10-27-2025
- SWK 11-04-2025
- Dividend Yield
- BMRN N/A
- SWK 4.89%
- EPS Growth
- BMRN 59.53
- SWK N/A
- EPS
- BMRN 2.68
- SWK 2.90
- Revenue
- BMRN $3,094,001,000.00
- SWK $15,166,300,000.00
- Revenue This Year
- BMRN $13.32
- SWK $0.46
- Revenue Next Year
- BMRN $7.51
- SWK $3.65
- P/E Ratio
- BMRN $19.65
- SWK $23.45
- Revenue Growth
- BMRN 12.39
- SWK N/A
- 52 Week Low
- BMRN $50.76
- SWK $53.91
- 52 Week High
- BMRN $73.51
- SWK $93.63
- Technical
- Relative Strength Index (RSI)
- BMRN 53.30
- SWK 44.59
- Support Level
- BMRN $50.76
- SWK $66.50
- Resistance Level
- BMRN $53.49
- SWK $68.98
- Average True Range (ATR)
- BMRN 1.86
- SWK 2.42
- MACD
- BMRN 0.10
- SWK 0.04
- Stochastic Oscillator
- BMRN 52.73
- SWK 32.73
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.